Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Polycatechols: Promising Materials for Biomedical Applications

Catechol Functionalized Hyperbranched Polymers As Biomedical Materials

Novel cationic poly(ester-co-carbonate) materials functionalized with tertiary amine groups

Catechol-Based Antimicrobial Polymers

Biopolymer Coating for Particle Surface Engineering and Their Biomedical Applications

Natural polyphenols for drug delivery and tissue engineering construction: A review

Biomedical polymers: synthesis, properties, and applications

On-demand and negative-thermo-swelling tissue adhesive based on highly branched ambivalent PEG-catechol copolymers.

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Catechol chemistry inspired approach to construct self-cross-linked polymer nanolayers as versatile biointerfaces

DEAE/Catechol-Chitosan Conjugates as Bioactive Polymers: Synthesis, Characterization, and Potential Applications

Adhesive Catechol-Conjugated Hyaluronic Acid for Biomedical Applications: A Mini Review

An Approach to Obtain Polymers with Enhanced Muco- and Tissue Adhesion

Recent Advances in Degradable Biomedical Polymers for Prevention, Diagnosis and Treatment of Diseases

Advances in Polyphenol-based Carbon Dots for Biomedical Engineering Applications

A review of cellulose-based catechol-containing functional materials for advanced applications

Recent Advances of Metal–Polyphenol Coordination Polymers for Biomedical Applications

Biofunctional chitosan–biopolymer composites for biomedical applications

Dynamic Covalent Polymers for Biomedical Applications

Recent advances in utilization of pectins in biomedical applications: a review focusing on molecular structure-directing health-promoting properties

Cinnamaldehyde-Contained Polymers and Their Biomedical Applications